Dr. David Palma

Dr. David Palma, researcher at Lawson and radiation oncologist at London Health Sciences Centre (LHSC)

High-dose radiation can improve survival in cancer patients once thought incurable

Study successfully targeted the spread of cancer

LHSC: London Regional Cancer Program - 

Cancer that spreads from an original tumour to other parts of the body is generally considered incurable. In an international study led by Lawson Health Research Institute, the research institute of London Health Sciences Centre (LHSC), researchers challenged this idea by showing that high-dose radiation can improve survival in patients with cancer that has spread to five or less sites.

Sheila Fleming with Lawson Impact Award

Sheila Fleming at the 2018 Lawson Impact Awards

2018 Staff Award of Excellence: Sheila Fleming

Sheila Fleming recognized for her support of Lawson’s entire administration team and research community

Off­site - 

Sheila Fleming, executive assistant to Dr. David Hill, scientific director of Lawson Health Research Institute, was the recipient of a Staff Award of Excellence at the 2018 Lawson Impact Awards event this past spring.

In addition to carrying out her administrative support functions for Dr. Hill – in itself a significant responsibility – Fleming goes above and beyond to provide support in a variety of ways to the entire Lawson administration team and research community.

Chris Pin

Chris Pin, PhD, lead author on the study, has found that mutation of a gene called ATRXmay lead to increased risk of developing pancreatitis and pancreatic cancer in females.

Genetic mutation may increase risk of pancreatic cancer in females

Study marks first time a sex-specific genetic risk factor for pancreatic cancer has been identified

LHSC: Victoria Hospital - 

In a new study from Lawson Health Research Institute and Western University’s Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females. The study marks the first time a sex-specific genetic risk factor for pancreatic cancer has been identified.

Pages